Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Medios Logo
Medios Growth Score
2
CB Rank
2593338
Heat Score
37
Medios is an innovative specialty pharmaceutical company that manufactures and supplies patient-specific medicinal products.
Founded
obfuscation
PublicPost-IPO Secondary Berlin, Berlin, Germany1001-5000 medios.ag/en/
Manufacturing
Medical
Pharmaceutical
Therapeutics
Overview

Medios
Growth Score
2
Heat Score
37

Growth Score2
-7 pts
in past quarter
Heat Score 37
-7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Medios

CB Rank
2593338
Medios is an innovative specialty pharmaceutical company that manufactures and supplies patient-specific medicinal products.
Founded
obfuscation
PublicPost-IPO Secondary Berlin, Berlin, Germany1001-5000 medios.ag/en/
Manufacturing
Medical
Pharmaceutical
Therapeutics

Funding Rounds

Post-IPO Secondary
OBF
in
obfuscation

Key People

Details

Legal Name Medios AG
Operating Status Active
Stock Symbol  ETR:ILM1
Company Type For Profit
About the Company
Medios AG is one of the competency partners and solutions providers for specialty pharmaceuticals in Germany.
Phone Number +49 30 232 5668 00
Contact Email info@medios.ag
Predictions & Insights

Growth Insight

See this Growth Insight
Medios is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

Specialty Pharma Solutions
Medios provides pharmaceutical products for patients with rare or chronic diseases, focusing on personalized and complex therapies.
Patient-Specific Medicinal Products
Medios manufactures and supplies medicinal products customized to individual patient parameters and disease profiles.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Secondary - Medios Logo
Post-IPO Secondary - Medios
1
obfuscation
LuxempartPost-IPO Secondary
obfuscation
Post-IPO Secondary - Medios Logo
Post-IPO Secondary - Medios
1
obfuscation
LuxempartPost-IPO Secondary
obfuscation
Post-IPO Secondary - Medios Logo
Post-IPO Secondary - Medios
1
obfuscation
LuxempartPost-IPO Secondary
obfuscation
Post-IPO Secondary - Medios Logo
Post-IPO Secondary - Medios
1
obfuscation
LuxempartPost-IPO Secondary
obfuscation
Post-IPO Secondary - Medios Logo
Post-IPO Secondary - Medios
1
obfuscation
LuxempartPost-IPO Secondary

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Secondary - Medios Logo
Post-IPO Secondary - Medios
1
obfuscation
LuxempartPost-IPO Secondary
obfuscation
Post-IPO Secondary - Medios Logo
Post-IPO Secondary - Medios
1
obfuscation
LuxempartPost-IPO Secondary
obfuscation
Post-IPO Secondary - Medios Logo
Post-IPO Secondary - Medios
1
obfuscation
LuxempartPost-IPO Secondary
obfuscation
Post-IPO Secondary - Medios Logo
Post-IPO Secondary - Medios
1
obfuscation
LuxempartPost-IPO Secondary
obfuscation
Post-IPO Secondary - Medios Logo
Post-IPO Secondary - Medios
1
obfuscation
LuxempartPost-IPO Secondary

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Luxempart Logo
Luxempart
Yes
Post-IPO Secondary - Medios Logo
Post-IPO Secondary - Medios
—
Luxempart Logo
Luxempart
Yes
Post-IPO Secondary - Medios Logo
Post-IPO Secondary - Medios
—
Luxempart Logo
Luxempart
Yes
Post-IPO Secondary - Medios Logo
Post-IPO Secondary - Medios
—
Luxempart Logo
Luxempart
Yes
Post-IPO Secondary - Medios Logo
Post-IPO Secondary - Medios
—
Luxempart Logo
Luxempart
Yes
Post-IPO Secondary - Medios Logo
Post-IPO Secondary - Medios
—

Investments

Number of Acquisitions 3

Investment Breakdown

Number of Acquisitions 3
Market Intelligence
People
View Profiles & Contacts
Headcount 1001-5000 Employee Profiles 1 Contacts 12

Employee Profiles

News

News and Press

News•Aug 13, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 11, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 1, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 22, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$44.6MThis year, Medios is projected to spend $44.6M on IT, according to Aberdeen.

Actively Used Products

6Medios uses 6 technology products and services including HTML5, Microsoft Outlook, and  Apache Server, according to G2 Stack.

Active Website Tech Count

19Medios is actively using 19 technologies for its website, according to BuiltWith. These include Common Crawl, HSTS, and  DNSSEC.
Sub-Organizations
Frequently Asked Questions

Where is Medios's headquarters? Medios is located in Berlin, Berlin, Germany.Who invested in Medios? Medios is funded by Luxempart.When was the last funding round for Medios? Medios closed its last funding round on
obfuscation
from a Post-IPO Secondary round.Who are Medios's competitors? Alternatives and possible competitors to Medios may include HWI Group, Venus Pharma, and  Dr. Max.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(7f45e42 1)
|